3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
30
Genitourinary
8
Thoracic
6
Gynecologic
5
Dermatologic
5
Breast
5
Gastrointestinal
4
Lymphoid
3
Plasma cell
2
Other hematologic neoplasm
2
Myeloid
2
Sarcoma
1
Other solid neoplasm
1
Other neoplasm
1
CNS
1
Conditions
Advanced Solid Tumors
357
Unspecified Adult Solid Tumor, Protocol Specific
302
Advanced Solid Tumor
274
Solid Tumor
237
Solid Tumors
233
Mesothelioma
84
Mesothelioma, Malignant
79
Solid Tumor, Adult
65
Carcinoma, Non-Small-Cell Lung
57
Ovarian Neoplasms
38
Melanoma
35
Lung Neoplasms
29
Advanced or Metastatic Solid Tumors
27
Neoplasms
26
Carcinoma, Renal Cell
26
Uterine Cervical Neoplasms
25
Stomach Neoplasms
25
Pancreatic Neoplasms
25
Solid Tumours
24
Sarcoma
24
Colorectal Neoplasms
24
Retinoblastoma
22
Esophageal Neoplasms
22
Advanced Malignant Solid Tumors
22
Unspecified Childhood Solid Tumor, Protocol Specific
21
Squamous Cell Carcinoma of Head and Neck
20
Breast Neoplasms
20
Advanced Solid Tumours
20
Triple Negative Breast Neoplasms
19
Small Cell Lung Carcinoma
19
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Oropharyngeal Neoplasms
×
Other solid neoplasm
×
Clear all
NCT04301011
2025-04-23
RAPTOR
Turnstone Biologics, Corp.
Phase 1
Terminated
27 enrolled